Beyond their role in antigen cross-presentation, cDC1s are the major source of IL-12 production and thus influence anti-tumor immunity by activating NK cells and driving CD4 T cell responses toward Th1 responses (19, 62–64). The gene discussed is CD4; the disease is neoplasm.